These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25506631)

  • 1. Longevity and determinants of protective humoral immunity after pandemic influenza infection.
    Sridhar S; Begom S; Hoschler K; Bermingham A; Adamson W; Carman W; Riley S; Lalvani A
    Am J Respir Crit Care Med; 2015 Feb; 191(3):325-32. PubMed ID: 25506631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Persistence of Cell-Mediated and Humoral Responses to A(H1N1)pdm09 Influenza Virus Vaccines and the Role of the AS03 Adjuvant System in Adults during Two Randomized Controlled Trials.
    van der Most RG; Clément F; Willekens J; Dewé W; Walravens K; Vaughn DW; Leroux-Roels G
    Clin Vaccine Immunol; 2017 Jun; 24(6):. PubMed ID: 28446441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responses to A(H1N1)pdm09 influenza vaccines in participants previously vaccinated with seasonal influenza vaccine: a randomized, observer-blind, controlled study.
    Roy-Ghanta S; Van der Most R; Li P; Vaughn DW
    J Infect Dis; 2014 Nov; 210(9):1419-30. PubMed ID: 24864125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
    Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
    Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single dose vaccination of the ASO3-adjuvanted A(H1N1)pdm09 monovalent vaccine in health care workers elicits homologous and cross-reactive cellular and humoral responses to H1N1 strains.
    Lartey S; Pathirana RD; Zhou F; Jul-Larsen Å; Montomoli E; Wood J; Cox RJ
    Hum Vaccin Immunother; 2015; 11(7):1654-62. PubMed ID: 26009966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responses to pandemic ASO3-adjuvanted A/California/07/09 H1N1 influenza vaccine in human immunodeficiency virus-infected individuals.
    Kelly D; Burt K; Missaghi B; Barrett L; Keynan Y; Fowke K; Grant M
    BMC Immunol; 2012 Aug; 13():49. PubMed ID: 22937824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral and cellular responses to a non-adjuvanted monovalent H1N1 pandemic influenza vaccine in hospital employees.
    Herrera MT; Gonzalez Y; Juárez E; Hernández-Sánchez F; Carranza C; Sarabia C; Guzman-Beltran S; Manjarrez ME; Muñoz-Torrico M; Garcia-Garcia L; Sada E; Torres M
    BMC Infect Dis; 2013 Nov; 13():544. PubMed ID: 24238117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host immune response to A(H1N1)pdm09 vaccination and infection: a one-year prospective study on six cohorts of subjects.
    Liu W; Ma MJ; Tang F; He C; Zhang XA; Jiang LF; Xin DS; Hu CY; Looman C; Cao WC
    Vaccine; 2012 Jul; 30(32):4785-9. PubMed ID: 22633868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody responses against influenza A(H1N1)pdm09 virus after sequential vaccination with pandemic and seasonal influenza vaccines in Finnish healthcare professionals.
    Strengell M; Ikonen N; Ziegler T; Kantele A; Anttila VJ; Julkunen I
    Influenza Other Respir Viruses; 2013 May; 7(3):431-8. PubMed ID: 22913369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.
    Ahmed MS; Jacques LC; Mahallawi W; Ferrara F; Temperton N; Upile N; Vaughan C; Sharma R; Beer H; Hoschler K; McNamara PS; Zhang Q
    Antiviral Res; 2015 Feb; 114():106-12. PubMed ID: 25513756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection.
    Schmidt T; Dirks J; Enders M; Gärtner BC; Uhlmann-Schiffler H; Sester U; Sester M
    Eur J Immunol; 2012 Jul; 42(7):1755-66. PubMed ID: 22585549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral and cell-mediated immunity to pandemic H1N1 influenza in a Canadian cohort one year post-pandemic: implications for vaccination.
    Wagar LE; Rosella L; Crowcroft N; Lowcock B; Drohomyrecky PC; Foisy J; Gubbay J; Rebbapragada A; Winter AL; Achonu C; Ward BJ; Watts TH
    PLoS One; 2011; 6(11):e28063. PubMed ID: 22132212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and persistence of the humoral and cellular immune responses induced by 2 doses of an AS03-adjuvanted A(H1N1)pdm09 pandemic influenza vaccine administered to infants, children and adolescents: Two open, uncontrolled studies.
    Garcia-Sicilia J; Arístegui J; Omeñaca F; Carmona A; Tejedor JC; Merino JM; García-Corbeira P; Walravens K; Bambure V; Moris P; Caplanusi A; Gillard P; Dieussaert I
    Hum Vaccin Immunother; 2015; 11(10):2359-69. PubMed ID: 26176592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difference in immune response in vaccinated and unvaccinated Swedish individuals after the 2009 influenza pandemic.
    Magalhaes I; Eriksson M; Linde C; Muhammad R; Rane L; Ambati A; Axelsson-Robertson R; Khalaj B; Alvarez-Corrales N; Lapini G; Montomoli E; Linde A; Pedersen NL; Maeurer M
    BMC Infect Dis; 2014 Jun; 14():319. PubMed ID: 24916787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response to influenza A(H1N1)pdm09 in vaccinated, serologically infected and unaffected pregnant women and their newborns.
    Helmig RB; Maimburg RD; Erikstrup C; Nielsen HS; Petersen OB; Nielsen LP; Hvidman L; Veirum JE; Henriksen TB; Storgaard M
    Acta Obstet Gynecol Scand; 2015 Aug; 94(8):833-9. PubMed ID: 25958884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seasonal influenza vaccines induced high levels of neutralizing cross-reactive antibody responses against different genetic group influenza A(H1N1)pdm09 viruses.
    Haveri A; Ikonen N; Kantele A; Anttila VJ; Ruotsalainen E; Savolainen-Kopra C; Julkunen I
    Vaccine; 2019 May; 37(20):2731-2740. PubMed ID: 30954308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of Influenza Vaccines: Evidence for Differential Effect of Secondary Vaccination on Humoral and Cellular Immunity.
    Rosendahl Huber SK; Hendriks M; Jacobi RHJ; van de Kassteele J; Mandersloot-Oskam JC; van Boxtel RAJ; Wensing AMJ; Rots NY; Luytjes W; van Beek J
    Front Immunol; 2018; 9():3103. PubMed ID: 30761157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine.
    Tete SM; Jul-Larsen Å; Rostami S; Lunde THF; Søland H; Krammer F; Cox RJ
    Vaccine; 2018 Apr; 36(16):2213-2219. PubMed ID: 29548607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza A(H1N1)pdm09 antibodies after pandemic and trivalent seasonal influenza vaccination as well as natural infection in November 2010 in Hamburg, Germany.
    Cramer J; Mac T; Hogan B; Stauga S; Eberhardt S; Wichmann O; Mertens T; Burchard G
    Euro Surveill; 2012 Jan; 17(2):. PubMed ID: 22264864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and humoral cross-immunity against two H3N2v influenza strains in presumably unexposed healthy and HIV-infected subjects.
    Agrati C; Castilletti C; Cimini E; Lapa D; Quartu S; Caglioti C; Lanini S; Cattoli G; Martini F; Ippolito G; Capobianchi MR
    PLoS One; 2014; 9(8):e105651. PubMed ID: 25162670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.